Ankara Yildirim Beyazıt University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Ankara Turkey (2010)

Organization Overview

First Clinical Trial
2010
NCT01264003
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ankara City Hospital Bilkent | Ankara Diskapi Training and Research Hospital | Ankara Yıldırım Beyazıt Üniversitesi | Ankara Yildirim Beyazıt University | Ankara Yıldırım Beyazıt University Faculty of Health Sciences | Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Nursing | Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation | Ankara Yildirim Beyazit University, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department | Ankara Yildirim Beyazit University,Faculty of Health Sciences, Physiotherapy and Rehabilitation Department ANKARA, Turkey, 06760 | Ankara Yildirim Beyazit University Faculty of Medicine | Ataturk Training and Research Hospital | Ayşegül Akca | Dilek Aktaş | Diskapi Teaching and Research Hospital | Ebru İnan Kırmızıgül | Gonca Karataş Baran | Health Sciences University Diskapi Yildirim Beyazit Education and Research Hospital | Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey | Yıldırım Beyazıt University Medical Pharmacology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 4)

Apnea (Phase 4)

Fistula (Phase 4)

Gastroenteritis (Phase 4)

Hemorrhoids (Phase 4)

Hernia (Phase 4)

Hernia, Inguinal (Phase 4)

Hyperplasia (Phase 4)

Ischemia (Phase 4)

Myocardial Ischemia (Phase 4)

Parkinson Disease (Phase 4)

Prostatic Hyperplasia (Phase 4)

Rectal Fistula (Phase 4)

Reperfusion Injury (Phase 4)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Tachycardia (Phase 4)

Urinary Bladder Neoplasms (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 61
  • # of Trial APIs: 37